What is the appropriate workup and management for a postmenopausal woman with elevated testosterone?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Workup and Management of Elevated Testosterone in Postmenopausal Women

In a postmenopausal woman with elevated testosterone, you must urgently exclude androgen-secreting tumors of the ovary or adrenal gland, which are rare but life-threatening causes that require immediate surgical intervention.

Initial Assessment Priority

The critical first step is determining the degree of testosterone elevation and associated clinical features, as these guide the urgency and extent of workup 1, 2.

Red Flags Requiring Urgent Evaluation

Look specifically for:

  • Rapid onset or progression of symptoms (weeks to months rather than years)
  • Virilization signs: clitoromegaly, deepening voice, increased muscularity, male-pattern baldness
  • Severe hirsutism: particularly if sudden or worsening
  • Testosterone levels in male range (typically >150-200 ng/dL or >5.2-6.9 nmol/L)
  • Palpable abdominal or pelvic mass

These features significantly increase the likelihood of an androgen-secreting tumor, which occurs in approximately 1-3 per 1000 patients with hyperandrogenism but represents a critical diagnosis not to miss 1.

Diagnostic Workup Algorithm

Step 1: Confirm and Quantify Hyperandrogenism

Measure early morning (before 10 AM) total testosterone using a reliable assay method 3, 4. Mass spectrometry is the gold standard, as immunoassays can be unreliable at low levels 4.

If total testosterone is elevated, obtain:

  • DHEAS (dehydroepiandrosterone sulfate): DHEAS >600 µg/dL (>16,000 nmol/L) suggests adrenal source and mandates immediate adrenal imaging 4
  • Free testosterone or calculate free testosterone if total testosterone is borderline
  • SHBG (sex hormone-binding globulin): Often decreased in metabolic syndrome, affects interpretation of total testosterone 4
  • Androstenedione: May be elevated when testosterone is borderline 4

Step 2: Exclude Medication-Induced Causes

Review medications carefully:

  • Anabolic steroids (consider in athletes, patients with sexual dysfunction)
  • Valproic acid (only anticonvulsant that raises testosterone) 3
  • Danazol
  • Testosterone products (prescribed or over-the-counter supplements)

Step 3: Rule Out Other Endocrinopathies

Based on clinical suspicion, assess for 3:

  • Cushing syndrome: If central obesity, striae, easy bruising, proximal weakness present
  • Hyperprolactinemia: Measure prolactin
  • Thyroid dysfunction: TSH
  • Acromegaly: If coarse features, enlarged hands/feet present
  • Congenital adrenal hyperplasia (late-onset): Early morning 17-hydroxyprogesterone if high-risk ethnicity (Ashkenazi Jewish, Hispanic, Slavic) 3

Step 4: Imaging Studies

The imaging approach depends on testosterone level and DHEAS:

If DHEAS >600 µg/dL:

  • Abdominal CT or MRI to evaluate adrenal glands for adenoma or carcinoma 4, 1

If testosterone markedly elevated (>150-200 ng/dL) with normal/mildly elevated DHEAS:

  • Transvaginal ultrasound as initial test
  • Pelvic MRI if ultrasound inconclusive or high suspicion for ovarian tumor 1, 2
  • Consider abdominal MRI to evaluate both adrenals and ovaries simultaneously 5

Important caveat: Imaging may be falsely negative in up to 50% of cases of ovarian hyperthecosis and some small androgen-secreting tumors 6, 5. A negative imaging study does NOT exclude a tumor.

Differential Diagnosis in Postmenopausal Women

The most common causes in descending order of frequency 1, 7, 2:

  1. Ovarian hyperthecosis: Non-neoplastic ovarian androgen overproduction, often associated with insulin resistance
  2. Polycystic ovary syndrome (PCOS): May worsen or become apparent after menopause
  3. Ovarian androgen-secreting tumors: Sertoli-Leydig cell tumors, thecomas, granulosa cell tumors
  4. Adrenal adenomas or carcinomas: Less common than ovarian but more likely malignant
  5. Late-onset congenital adrenal hyperplasia
  6. Iatrogenic: Exogenous androgen use

Management Strategy

If Tumor Suspected (High Testosterone, Virilization, or Positive Imaging)

Surgical removal is the definitive treatment 1. Refer urgently to gynecologic oncology (for ovarian) or endocrine surgery (for adrenal).

If No Tumor Identified but Significant Hyperandrogenism Persists

For patients who are poor surgical candidates or imaging-negative:

GnRH agonist therapy (leuprolide) is the most effective medical management for ovarian-source hyperandrogenism 6, 5. This approach:

  • Dramatically reduces testosterone levels within 1 month
  • Confirms ovarian source if effective
  • Can be used long-term in non-surgical candidates

Important limitations:

  • Causes significant menopausal symptoms (hot flashes, mood changes, sleep disturbance) that may lead to discontinuation 5
  • Does not definitively exclude tumor (rare cases of gonadotropin-responsive tumors exist) 6
  • Expensive and often not covered by insurance for this indication 5

Alternative/adjunctive therapies:

  • Spironolactone (antiandrogen): For mild-moderate hirsutism
  • Finasteride: 5α-reductase inhibitor for hirsutism
  • Cosmetic measures: Laser hair removal, electrolysis

If Mild Elevation Without Concerning Features

Monitor clinically and biochemically every 3-6 months. Worsening symptoms or rising testosterone levels mandate complete re-evaluation with imaging 2.

Critical Pitfalls to Avoid

  1. Do not dismiss elevated testosterone as "normal aging" in postmenopausal women—this requires evaluation 1, 2
  2. Do not rely solely on imaging—negative imaging does not exclude tumor or hyperthecosis 6, 5
  3. Do not use unreliable testosterone assays—insist on mass spectrometry or high-quality immunoassays from specialty laboratories 3, 4
  4. Do not forget to check DHEAS—this is critical for localizing the source 4
  5. Do not assume PCOS—while common in premenopausal women, in postmenopausal women with new-onset hyperandrogenism, tumor must be excluded first 1

Long-term Considerations

Elevated testosterone in postmenopausal women is associated with increased cardiovascular risk, insulin resistance, and metabolic syndrome 1, 2. Even if no tumor is found, addressing hyperandrogenism improves quality of life and may reduce long-term metabolic complications 7.

The evidence base for postmenopausal hyperandrogenism is limited, with most guidelines extrapolated from premenopausal women 3. The recent literature emphasizes the importance of not missing tumors while recognizing that most cases are non-neoplastic and can be managed medically if surgery is not feasible 1, 6, 5, 2.

References

Research

Postmenopausal hyperandrogenism.

Climacteric : the journal of the International Menopause Society, 2022

Research

Hyperandrogenism after menopause: diagnostic evaluation.

Climacteric : the journal of the International Menopause Society, 2025

Guideline

recommendations for investigation of hyperandrogenism.

Annales d'endocrinologie, 2010

Research

Hyperandrogenism in a postmenopausal woman: diagnostic and therapeutic challenges.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2011

Research

Postmenopausal Hyperandrogenism: Evaluation and Treatment Strategies.

Endocrinology and metabolism clinics of North America, 2021

Related Questions

What are the possible causes of elevated testosterone and dihydrotestosterone in a postmenopausal woman who is not receiving hormone replacement therapy?
What is the differential diagnosis for hyperandrogenemia (elevated testosterone) in a female patient?
What are the current recommendations or guidelines for testosterone therapy in postmenopausal women?
What is the daily prescription (number of clicks) for a testosterone cream with a concentration of 2 mg/mL dispensed by a Topi‑Click dispenser that delivers 0.25 mL per click?
In a 30-year-old male with normal testosterone who has low libido and mental health concerns, what further evaluation and treatment should be pursued?
Why does hyperkalemia cause sinus node dysfunction?
Can doxycycline be used to treat eczema (atopic dermatitis)?
What is the assessment for an 82‑year‑old man with end‑stage heart failure with reduced ejection fraction (EF 25‑30 %) on palliative milrinone, implanted cardioverter‑defibrillator, prior coronary artery bypass graft, chronic hypoxemic respiratory failure on 2 L home oxygen, type‑2 diabetes mellitus, chronic kidney disease stage IV, prior pontine cerebrovascular accident, colon cancer in remission, recent Enterobacter cloacae and Stenotrophomonas maltophilia septicemia, now presenting with cough and worsening dyspnea, volume overload on aggressive intravenous diuresis, and resolved atrial fibrillation with rapid ventricular response?
What is the recommended treatment and preventive protocol for poison‑ivy dermatitis in a landscaper with frequent occupational exposure?
Is empagliflozin (Jardiance) safe for a renal transplant patient who is prone to dehydration during hot summer months?
Can pancreatitis lead to the development of ascites?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.